CDC-RFA-DP-24-0048: State Promotion of Strategies to Advance Oral Health
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control - NCCDPHP notices from 2024.
Centers for Disease Control - NCCDPHP offered grants of up to $525,000 (at least $250,000) to any type of organization. It expected to make about 15 awards worth $17.1 million in total. Applications closed on May 28, 2024.
From the official notice on Grants.gov, last changed April 29, 2024. Checked November 7, 2026.
- Award ceiling$525,000
- Award floor$250,000
- Total funding$17.1 million
- Expected awards15
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | March 25, 2024 |
|---|---|
| Deadline | May 28, 2024 |
| Archived by Grants.gov | June 27, 2024 |
Who can apply
This opportunity was open to any type of organization.
All 16 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
N/A
Is this a realistic fit?
- Past State Actions to Improve Oral Health Outcomes and Partner Actions to Improve Oral Health Outcomes awards averaged $1.3 million; this notice allows up to $525,000 per award.
- Most of the program's money (100% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
State Promotion of Strategies to Advance Oral Health is a three-year competitive announcement that continues the Centers for Disease Control and Prevention's investment in supporting oral health programs. This Funding Opportunity Announcement aims to enable recipients to focus on priority populations and the following strategies: 1) access to optimally fluoridated water and receipt of Evidence-based Preventive Dental Services, 2) adherence to infection prevention and control recommendations, 3) access to data to build evidence for public health practice, and 4) access to care and untreated decay, and 5) foundational information supporting integrated medical and dental services for persons with diabetes. The proposed program follows previous Notice of Funding Opportunities (NOFOs) and incorporates programmatic strategies implemented in NOFO DP18-1810 [FY2018 – FY2023].
Who has won State Actions to Improve Oral Health Outcomes and Partner Actions to Improve Oral Health Outcomes grants before
From fiscal 2021 to 2025, State Actions to Improve Oral Health Outcomes and Partner Actions to Improve Oral Health Outcomes (93.366) awarded $25.3 million across 20 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Colorado Department of Public Health & Environment | Colorado | 1 | $1.8 million |
| North Dakota Department of Health and Human Services | North Dakota | 1 | $1.7 million |
| Virginia Department of Health | Virginia | 1 | $1.7 million |
| South Carolina Department of Public Health | South Carolina | 1 | $1.7 million |
| Department of Public Health Connecticut | Connecticut | 1 | $1.7 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-DP-24-0048 still open?
No. It closed on May 28, 2024.
Who can apply for State Promotion of Strategies to Advance Oral Health?
Centers for Disease Control - NCCDPHP accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for State Promotion of Strategies to Advance Oral Health?
Closed May 28, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $525,000 each. About $17.1 million in total across about 15 awards.
Who has won State Actions to Improve Oral Health Outcomes and Partner Actions to Improve Oral Health Outcomes grants before?
The largest recipients over five fiscal years were Colorado Department of Public Health & Environment, North Dakota Department of Health and Human Services, Virginia Department of Health. The program made 20 awards worth $25.3 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)